Mir-15B-5P Is Involved in Doxorubicin-Induced Cardiotoxicity Via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte

Total Page:16

File Type:pdf, Size:1020Kb

Mir-15B-5P Is Involved in Doxorubicin-Induced Cardiotoxicity Via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte Cardiovascular Toxicology (2019) 19:264–275 https://doi.org/10.1007/s12012-018-9495-6 MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte Guo‑xing Wan1 · Lan Cheng1 · Hai‑lun Qin1 · Yun‑zhang Zhang1 · Ling‑yu Wang1 · Yong‑gang Zhang1 Published online: 7 December 2018 © Springer Science+Business Media, LLC, part of Springer Nature 2018 Abstract The wide use of anthracyclines represented by doxorubicin (DOX) has benefited cancer patients, yet the clinical applica- tion is limited due to its cardiotoxicity. Although numerous evidences have supported a role of microRNAs (miRNAs) in DOX-induced myocardial damage, the exact etiology and pathogenesis remain largely obscure. In this study, we focused on the role of miR-15b-5p in DOX-induced cardiotoxicity. We employed a public miRNA and gene microarray to screen differentially expressed miRNAs (DEMs) and differentially expressed genes (DEGs) in rat cardiomyocytes, and 33 DEMs including miR-15b-5p and 237 DEGs including Bmpr1a and Gata4 were identified. The Gene ontology (GO) and pathway enrichment analysis of 237 DEGs indicated that the DEGs were mainly enriched in heart development and ALK pathway in cardiomyocyte which included the main receptor Bmpr1a and transcription factor Gata4. The up-regulated miR-15b-5p and down-regulated Bmpr1a and Gata4 mRNA expressions were further validated in H9c2 cardiomyocytes exposed to DOX. Moreover, the results showed overexpression of miR-15b-5p or inhibition of Bmpr1a may enhance the DOX-induced apop- tosis, oxidative stress and mitochondria damage in H9c2 cardiomyocytes. The Bmpr1a was suggested as a potential target of miR-15b-5p by bioinformatics prediction. We further verified the negatively regulatory effect of miR-15b-5p on Bmpr1a signaling. Moreover, we also confirmed that overexpression of miR-15b-5p may exacerbate the DOX-induced apoptosis of H9c2 cardiomyocytes by affecting the protein expression ratio of Bcl-2/Bax and Akt activation, while this pro-apoptotic effect was able to be suppressed by Bmpr1a agonist. Collectively, the results suggest that miR-15b-5p is likely involved in doxorubicin-induced cardiotoxicity via inhibiting Bmpr1a signaling in H9c2 cardiomyocytes. Our study provides a novel insight for investigating DOX-induced cardiotoxicity. Keywords MiR-15b-5p · Bmpr1a · Doxorubicin · Cardiotoxicity Introduction m2, the incidence of heart failure or left ventricular dys- function rises from 5 to 48% [2], which may impair the sur- Doxorubicin (DOX) is one of the most widely used and vival benefit DOX treatment brings. Current evidences have forceful anthracycline agents, delivering anti-cancer activ- proposed several mechanisms accounting for DOX-induced ity against numerous types of malignancy. However, the cardiotoxicity, including oxidative stress, inflammation, lipid clinical benefit of DOX treatment has been limited by its peroxidation, mitochondrial impairment, intracellular cal- cumulative and dose-dependent cardiotoxicity [1]. With an cium dysregulation and inhibitory topoisomerase II (Top2), accumulation dose of DOX increased from 400 to 700 mg/ which may be involved in irreversible myocardial damage and apoptosis [3–5]. Nevertheless, the exact mechanisms remain poorly understood. Handling Editor: Gen Suzuki. MicroRNAs (miRNAs) as key players in gene expres- sion regulation by altering the translation or stability of tar- * Yong-gang Zhang get mRNAs have been found functionally participated in [email protected] heart development, function, and diseases including DOX- 1 Department of Cardiology, The Second Affiliated induced cardiotoxicity [6]. Recently, miR-15b was found up- Hospital of Shantou University Medical College, regulated in the mice ischemia reperfusion (I/R) model [7]. Dongxia North Road, Shantou 515041, Guangdong, Similarly, miR-15b was also reported to enhance hypoxia/ People’s Republic of China Vol:.(1234567890)1 3 Cardiovascular Toxicology (2019) 19:264–275 265 reoxygenation (H/R)-induced apoptosis of cardiomyocytes Gene Ontology (GO) and Pathway Enrichment via a mitochondrial apoptotic pathway [8]. Conversely, the Analysis of DEGs suppression of miR-15b was able to prevent rapid loss of cardiac function in an induced cardiac dysfunction model GO enrichment analysis of DEGs was implemented with the in adult mice [9]. Moreover, the inhibition of miR-15b was clusterProfiler package [14]. GO terms (molecular function found capable of decreasing apoptosis in neonatal rat cardiac and biological processes) with adjust p value < 0.05 were myocytes by modulating cellular adenosine triphosphate considered significantly enriched by DEGs. The clusterPro- (ATP) level and mitochondrial integrity [10]. Consequently, filer involving Kyoto Encyclopedia of Genes and Genomes the current findings suggested that the manipulation of miR- (KEGG), Reactome and Molecular Signatures Database 15b was likely developed for therapeutic approaches [9]. (MSigDb) pathway datasets was used to perform pathway However, the role of miR-15b in DOX-induced cardiotoxic- enrichment analysis to expound promising signaling path- ity remains largely unknown. ways correlated with the DEGs, and p value < 0.05 with In this study, the differentially expressed miRNAs in adjust p value < 0.05 were defined as the cut-off criteria. DOX-treated cardiomyocytes were identified by using a public microarray dataset. We focused on the role of miR- Bioinformatics Prediction of miR‑15b‑5p Targets 15b in the cardiomyocytes exposed to DOX, and explored the underlying mechanism, which may provide a valuable First, to list the putative targets of miR-15b-5p, a vast insight to protect against DOX-induced cardiotoxicity. search in mirWalk database (http://zmf.umm.unihe idelb erg.de/apps/zmf/mirwa lk2/) was performed, in which the miRwalk, miRanda, miRNAMap and Targetscan databases Materials and Methods were included. Each target gene must be searched in at least three databases. Commonly, miRNAs negatively regulated Chemicals and Materials the expression of its targets. The candidate targets were nar- rowed down by an intersection with the DEGs and were DOX was obtained from Hisun-Pfizer Pharmaceutical Co., further selected by a negative correlation with miR-15b-5p Ltd. (Zhejiang, China), which was dissolved in PBS. Protein expression. Extraction Kit was obtained from KEYGEN Biotech. Co., Ltd. (Nanjing, China). The ROS assay kit, mitochondrial Cell Culture and Transfection Experiments membrane potential assay kit with JC-1, cell lysis buffer and phenylmethanesulfonyl fluoride (PMSF) were obtained The H9c2 cardiomyocytes were obtained from the Shang- from Beyotime Institute of Biotechnology (Jiangsu, China). hai Institutes for Biological Sciences (Shanghai, China), The Annexin V-FITC Apoptosis Detection Kit was pur- routinely grown in Dulbecco’s Modified Eagle (DMEM) chased from BestBio Science (Shanghai, China). 20 ng/ml medium supplemented with 12% fetal bovine serum in a recombinant human bone morphogenetic protein (rhBMP, humidified atmosphere of 5% CO at 37 °C. The cardiomyo- Bmpr1a agonist) was purchased from PrimeGene Biotech- 2 cytes were exposed to DOX at the concentration of 6 µM for nology (Shanghai, China), and the 30 nM Bmpr1a inhibitor 24 h as previously described [2, 15]. H9c2 cardiomyocytes LDN193189 was obtained from MedChemExpress China at 80% confluence were transfected with rno-miR-15-5p (Shanghai, China). mimics (5′-UAG CAG CAC AUC AUG GUU UACA-3′) or rno-miR-15-5p inhibitors (5′-UGU AAA CCA UGA UGU Microarray Analysis GCU GCUA-3′), or scrambled controls (Gene Pharma, Shanghai, China), respectively, at a concentration of 20 µM The miRNA(GSE36239) and gene expression with the use of Lipofectamine 2000(Invitrogen) according profile(GSE42177) were downloaded from the public GEO to the manufacturer’s protocol. All the transfections were database (www. ncbi.nlm.gov/geo/) [1, 11], The selected performed subsequent to the rhBMP (Bmpr1a agonist) or array data in GSE36239 dataset consisted of three primary LDN193189 (Bmpr1a inhibitor) treatment for 30 min. rat cardiomyocytes samples treated with DOX and three controls, and similar design and treatment were given in Apoptosis Assay, Measurement of Mitochondrial GSE42177. After data processing as previous [12], dif- Membrane Potential (MMP), and Intracellular ROS ferentially expressed miRNAs (DEMs) and differentially expressed genes (DEGs) were identified by significance The apoptosis, oxidative stress, and mitochondria dam- analysis of the microarrays with the limma package [13], age were common hallmarks of DOX-induced myocardial following the criteria p < 0.05 and |logFC| > 1. 1 3 266 Cardiovascular Toxicology (2019) 19:264–275 damage. To examine the influence of interfering miR- Western Blotting Assay 15b-5p or Bmpr1a on apoptosis, MMP and ROS, the experiment was grouped as follows: (1) for interfering To examine the effect of miR-15b-5p targeting Bmpr1a miR-15b-5p: control, DOX, DOX + miR-15b-5p mimic signal on cell apoptosis and survival of H9c2 cardiomyo- (20 µM), DOX + miR-15b-5p inhibitor(20 µM); (2) for cytes, the Bcl-2/Bax protein expression ratio (for anti- interfering Bmpr1a: control, DOX, DOX + rhBMP (20 ng/ apoptosis) and Akt activation (for survival) was detected ml), DOX + LDN193189(30 nM). The H9c2 cardiomyo- by western blotting, and the experiment was designed as cytes were plated in 6-well culture plates at a density of that in the RT-qPCR array. The extraction and detection 5 × 104 cells/mL and then treated with DOX
Recommended publications
  • Gene Symbol Gene Description ACVR1B Activin a Receptor, Type IB
    Table S1. Kinase clones included in human kinase cDNA library for yeast two-hybrid screening Gene Symbol Gene Description ACVR1B activin A receptor, type IB ADCK2 aarF domain containing kinase 2 ADCK4 aarF domain containing kinase 4 AGK multiple substrate lipid kinase;MULK AK1 adenylate kinase 1 AK3 adenylate kinase 3 like 1 AK3L1 adenylate kinase 3 ALDH18A1 aldehyde dehydrogenase 18 family, member A1;ALDH18A1 ALK anaplastic lymphoma kinase (Ki-1) ALPK1 alpha-kinase 1 ALPK2 alpha-kinase 2 AMHR2 anti-Mullerian hormone receptor, type II ARAF v-raf murine sarcoma 3611 viral oncogene homolog 1 ARSG arylsulfatase G;ARSG AURKB aurora kinase B AURKC aurora kinase C BCKDK branched chain alpha-ketoacid dehydrogenase kinase BMPR1A bone morphogenetic protein receptor, type IA BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) BRAF v-raf murine sarcoma viral oncogene homolog B1 BRD3 bromodomain containing 3 BRD4 bromodomain containing 4 BTK Bruton agammaglobulinemia tyrosine kinase BUB1 BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) BUB1B BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) C9orf98 chromosome 9 open reading frame 98;C9orf98 CABC1 chaperone, ABC1 activity of bc1 complex like (S. pombe) CALM1 calmodulin 1 (phosphorylase kinase, delta) CALM2 calmodulin 2 (phosphorylase kinase, delta) CALM3 calmodulin 3 (phosphorylase kinase, delta) CAMK1 calcium/calmodulin-dependent protein kinase I CAMK2A calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha CAMK2B calcium/calmodulin-dependent
    [Show full text]
  • PARSANA-DISSERTATION-2020.Pdf
    DECIPHERING TRANSCRIPTIONAL PATTERNS OF GENE REGULATION: A COMPUTATIONAL APPROACH by Princy Parsana A dissertation submitted to The Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland July, 2020 © 2020 Princy Parsana All rights reserved Abstract With rapid advancements in sequencing technology, we now have the ability to sequence the entire human genome, and to quantify expression of tens of thousands of genes from hundreds of individuals. This provides an extraordinary opportunity to learn phenotype relevant genomic patterns that can improve our understanding of molecular and cellular processes underlying a trait. The high dimensional nature of genomic data presents a range of computational and statistical challenges. This dissertation presents a compilation of projects that were driven by the motivation to efficiently capture gene regulatory patterns in the human transcriptome, while addressing statistical and computational challenges that accompany this data. We attempt to address two major difficulties in this domain: a) artifacts and noise in transcriptomic data, andb) limited statistical power. First, we present our work on investigating the effect of artifactual variation in gene expression data and its impact on trans-eQTL discovery. Here we performed an in-depth analysis of diverse pre-recorded covariates and latent confounders to understand their contribution to heterogeneity in gene expression measurements. Next, we discovered 673 trans-eQTLs across 16 human tissues using v6 data from the Genotype Tissue Expression (GTEx) project. Finally, we characterized two trait-associated trans-eQTLs; one in Skeletal Muscle and another in Thyroid. Second, we present a principal component based residualization method to correct gene expression measurements prior to reconstruction of co-expression networks.
    [Show full text]
  • ACVR1 Antibody Cat
    ACVR1 Antibody Cat. No.: 4791 Western blot analysis of ACVR1 in A549 cell lysate with ACVR1 antibody at 1 μg/mL in (A) the absence and (B) the presence of blocking peptide. Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human, Mouse HOMOLOGY: Predicted species reactivity based on immunogen sequence: Bovine: (100%), Rat: (93%) ACVR1 antibody was raised against a 14 amino acid synthetic peptide near the amino terminus of the human ACVR1. IMMUNOGEN: The immunogen is located within the first 50 amino acids of ACVR1. TESTED APPLICATIONS: ELISA, WB ACVR1 antibody can be used for detection of ACVR1 by Western blot at 1 μg/mL. APPLICATIONS: Antibody validated: Western Blot in human samples. All other applications and species not yet tested. At least four isoforms of ACVR1 are known to exist. This antibody is predicted to have no SPECIFICITY: cross-reactivity to ACVR1B or ACVR1C. POSITIVE CONTROL: 1) Cat. No. 1203 - A549 Cell Lysate Properties October 1, 2021 1 https://www.prosci-inc.com/acvr1-antibody-4791.html PURIFICATION: ACVR1 Antibody is affinity chromatography purified via peptide column. CLONALITY: Polyclonal ISOTYPE: IgG CONJUGATE: Unconjugated PHYSICAL STATE: Liquid BUFFER: ACVR1 Antibody is supplied in PBS containing 0.02% sodium azide. CONCENTRATION: 1 mg/mL ACVR1 antibody can be stored at 4˚C for three months and -20˚C, stable for up to one STORAGE CONDITIONS: year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. Additional Info OFFICIAL SYMBOL: ACVR1 ACVR1 Antibody: FOP, ALK2, SKR1, TSRI, ACTRI, ACVR1A, ACVRLK2, Activin receptor type-1, ALTERNATE NAMES: Activin receptor type I, ACTR-I ACCESSION NO.: NP_001096 PROTEIN GI NO.: 4501895 GENE ID: 90 USER NOTE: Optimal dilutions for each application to be determined by the researcher.
    [Show full text]
  • By Submitted in Partial Satisfaction of the Requirements for Degree of in In
    Developments of Two Imaging based Technologies for Cell Biology Researches by Xiaowei Yan DISSERTATION Submitted in partial satisfaction of the requirements for degree of DOCTOR OF PHILOSOPHY in Biochemistry and Molecular Biology in the GRADUATE DIVISION of the UNIVERSITY OF CALIFORNIA, SAN FRANCISCO Approved: ______________________________________________________________________________Ronald Vale Chair ______________________________________________________________________________Jonathan Weissman ______________________________________________________________________________Orion Weiner ______________________________________________________________________________ ______________________________________________________________________________ Committee Members Copyright 2021 By Xiaowei Yan ii DEDICATION Everything happens for the best. To my family, who supported me with all their love. iii ACKNOWLEDGEMENTS The greatest joy of my PhD has been joining UCSF, working and learning with such a fantastic group of scientists. I am extremely grateful for all the support and mentorship I received and would like to thank: My mentor, Ron Vale, who is such a great and generous person. Thank you for showing me that science is so much fun and thank you for always giving me the freedom in pursuing my interest. I am grateful for all the guidance from you and thank you for always supporting me whenever I needed. You are a person full of wisdom, and I have been learning so much from you and your attitude to science, science community and even life will continue inspire me. Thank you for being my mentor and thank you for being such a great mentor. Everyone else in Vale lab, past and present, for making our lab a sweet home. I would like to give my special thank to Marvin (Marvin Tanenbaum) and Nico (Nico Stuurman), two other mentors for me in the lab. I would like to thank them for helping me adapt to our lab, for all the valuable advice and for all the happiness during the time that we work together.
    [Show full text]
  • TABLE S4: Proliferation-Related and Chromosomal Instability-Related
    TABLE S4: Proliferation-related and chromosomal instability-related genes up-regulated in ATC (weight <4.0) 44-gene Unigene Prolif. Prolif. Gene Gene description and (GO biological process) Number N1 N2 N3 N4 ATC1 ATC2 ATC3 ATC4 ATC5 Cluster1 CIN702 Signature3 Normal tissues ATC samples ASF1B anti-silencing function 1 homolog B (unknown) Hs.26516 0.2 0.3 0.3 0.3 0.8 0.8 1.1 0.8 0.4 yes AURKB aurora kinase B (cell cycle) Hs.442658 0.06 0.06 0.08 0.05 2.4 1.2 0.003 0.6 0.6 yes yes yes BIRC5 baculoviral IAP repeat-containing 5 (anti apoptosis) Hs.514527 0.7 0.3 0.4 0.3 0.8 0.5 0.5 0.6 0.6 yes yes budding uninhibited by benzimidazoles 1 homolog (mitotic BUB1 spindle checkpoint) Hs.469649 0.06 0.04 0.02 0.05 1.8 1.0 0.6 0.5 0.5 yes yes CCNE1 cyclin E1 (cell cycle) Hs.244723 0.5 0.4 0.5 0.6 1.3 1.4 2.2 1.5 1.1 yes CCNF cyclin F (cell cycle) Hs.1973 0.1 0.1 0.2 0.3 0.7 1.0 1.0 0.8 1.2 yes yes CDC45L CDC45 cell division cycle 45-like (cell cycle) Hs.474217 0.1 0.1 0.1 0.3 1.6 0.7 0.5 0.9 0.8 yes CDC6 cell division cycle 6 homolog (cell cycle) Hs. 405958 0.08 0.08 0.08 0.07 0.3 0.8 0.5 0.6 1 yes yes CDC7 cell division cycle 7 (cell cycle) Hs.533573 0.2 0.2 0.2 0.1 0.5 0.9 1 0.6 1.3 yes CDKN3 cyclin-dependent kinase inhibitor 3 (cell cycle) Hs.84113 0.1 0.1 0.7 0.1 0.9 0.8 0.6 0.4 6.2 yes CHEK1 CHK1 checkpoint homolog (cell cycle) Hs.
    [Show full text]
  • 1 AGING Supplementary Table 2
    SUPPLEMENTARY TABLES Supplementary Table 1. Details of the eight domain chains of KIAA0101. Serial IDENTITY MAX IN COMP- INTERFACE ID POSITION RESOLUTION EXPERIMENT TYPE number START STOP SCORE IDENTITY LEX WITH CAVITY A 4D2G_D 52 - 69 52 69 100 100 2.65 Å PCNA X-RAY DIFFRACTION √ B 4D2G_E 52 - 69 52 69 100 100 2.65 Å PCNA X-RAY DIFFRACTION √ C 6EHT_D 52 - 71 52 71 100 100 3.2Å PCNA X-RAY DIFFRACTION √ D 6EHT_E 52 - 71 52 71 100 100 3.2Å PCNA X-RAY DIFFRACTION √ E 6GWS_D 41-72 41 72 100 100 3.2Å PCNA X-RAY DIFFRACTION √ F 6GWS_E 41-72 41 72 100 100 2.9Å PCNA X-RAY DIFFRACTION √ G 6GWS_F 41-72 41 72 100 100 2.9Å PCNA X-RAY DIFFRACTION √ H 6IIW_B 2-11 2 11 100 100 1.699Å UHRF1 X-RAY DIFFRACTION √ www.aging-us.com 1 AGING Supplementary Table 2. Significantly enriched gene ontology (GO) annotations (cellular components) of KIAA0101 in lung adenocarcinoma (LinkedOmics). Leading Description FDR Leading Edge Gene EdgeNum RAD51, SPC25, CCNB1, BIRC5, NCAPG, ZWINT, MAD2L1, SKA3, NUF2, BUB1B, CENPA, SKA1, AURKB, NEK2, CENPW, HJURP, NDC80, CDCA5, NCAPH, BUB1, ZWILCH, CENPK, KIF2C, AURKA, CENPN, TOP2A, CENPM, PLK1, ERCC6L, CDT1, CHEK1, SPAG5, CENPH, condensed 66 0 SPC24, NUP37, BLM, CENPE, BUB3, CDK2, FANCD2, CENPO, CENPF, BRCA1, DSN1, chromosome MKI67, NCAPG2, H2AFX, HMGB2, SUV39H1, CBX3, TUBG1, KNTC1, PPP1CC, SMC2, BANF1, NCAPD2, SKA2, NUP107, BRCA2, NUP85, ITGB3BP, SYCE2, TOPBP1, DMC1, SMC4, INCENP. RAD51, OIP5, CDK1, SPC25, CCNB1, BIRC5, NCAPG, ZWINT, MAD2L1, SKA3, NUF2, BUB1B, CENPA, SKA1, AURKB, NEK2, ESCO2, CENPW, HJURP, TTK, NDC80, CDCA5, BUB1, ZWILCH, CENPK, KIF2C, AURKA, DSCC1, CENPN, CDCA8, CENPM, PLK1, MCM6, ERCC6L, CDT1, HELLS, CHEK1, SPAG5, CENPH, PCNA, SPC24, CENPI, NUP37, FEN1, chromosomal 94 0 CENPL, BLM, KIF18A, CENPE, MCM4, BUB3, SUV39H2, MCM2, CDK2, PIF1, DNA2, region CENPO, CENPF, CHEK2, DSN1, H2AFX, MCM7, SUV39H1, MTBP, CBX3, RECQL4, KNTC1, PPP1CC, CENPP, CENPQ, PTGES3, NCAPD2, DYNLL1, SKA2, HAT1, NUP107, MCM5, MCM3, MSH2, BRCA2, NUP85, SSB, ITGB3BP, DMC1, INCENP, THOC3, XPO1, APEX1, XRCC5, KIF22, DCLRE1A, SEH1L, XRCC3, NSMCE2, RAD21.
    [Show full text]
  • Emi1 (FBXO5) (Center) Rabbit Polyclonal Antibody Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for AP51634PU-N Emi1 (FBXO5) (Center) Rabbit Polyclonal Antibody Product data: Product Type: Primary Antibodies Applications: WB Recommended Dilution: ELISA: 1/1000. Western Blot: 1/100-1/500. Reactivity: Human Host: Rabbit Isotype: Ig Clonality: Polyclonal Immunogen: KLH conjugated synthetic peptide between 191-221 amino acids from the Central region of Human FBXO5. Specificity: This antibody recognizes Human FBXO5 (Center). Formulation: PBS containing 0.09% (W/V) Sodium Azide as preservative State: Aff - Purified State: Liquid purified Ig fraction Concentration: lot specific Purification: Affinity Chromatography on Protein A Conjugation: Unconjugated Storage: Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Stability: Shelf life: one year from despatch. Gene Name: Homo sapiens F-box protein 5 (FBXO5), transcript variant 2 Database Link: Entrez Gene 26271 Human Q9UKT4 This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 Emi1 (FBXO5) (Center) Rabbit Polyclonal Antibody – AP51634PU-N Background: This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination.
    [Show full text]
  • Signal Transduction Pathway Through Activin Receptors As a Therapeutic Target of Musculoskeletal Diseases and Cancer
    Endocr. J./ K. TSUCHIDA et al.: SIGNALING THROUGH ACTIVIN RECEPTORS doi: 10.1507/endocrj.KR-110 REVIEW Signal Transduction Pathway through Activin Receptors as a Therapeutic Target of Musculoskeletal Diseases and Cancer KUNIHIRO TSUCHIDA, MASASHI NAKATANI, AKIYOSHI UEZUMI, TATSUYA MURAKAMI AND XUELING CUI Division for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science (ICMS), Fujita Health University, Toyoake, Aichi 470-1192, Japan Received July 6, 2007; Accepted July 12, 2007; Released online September 14, 2007 Correspondence to: Kunihiro TSUCHIDA, Institute for Comprehensive Medical Science (ICMS), Fujita Health University, Toyoake, Aichi 470-1192, Japan Abstract. Activin, myostatin and other members of the TGF-β superfamily signal through a combination of type II and type I receptors, both of which are transmembrane serine/threonine kinases. Activin type II receptors, ActRIIA and ActRIIB, are primary ligand binding receptors for activins, nodal, myostatin and GDF11. ActRIIs also bind a subset of bone morphogenetic proteins (BMPs). Type I receptors that form complexes with ActRIIs are dependent on ligands. In the case of activins and nodal, activin receptor-like kinases 4 and 7 (ALK4 and ALK7) are the authentic type I receptors. Myostatin and GDF11 utilize ALK5, although ALK4 could also be activated by these growth factors. ALK4, 5 and 7 are structurally and functionally similar and activate receptor-regulated Smads for TGF-β, Smad2 and 3. BMPs signal through a combination of three type II receptors, BMPRII, ActRIIA, and ActRIIB and three type I receptors, ALK2, 3, and 6. BMPs activate BMP-specific Smads, Smad1, 5 and 8. Smad proteins undergo multimerization with co-mediator Smad, Smad4, and translocated into the nucleus to regulate the transcription of target genes in cooperation with nuclear cofactors.
    [Show full text]
  • Human Lectins, Their Carbohydrate Affinities and Where to Find Them
    biomolecules Review Human Lectins, Their Carbohydrate Affinities and Where to Review HumanFind Them Lectins, Their Carbohydrate Affinities and Where to FindCláudia ThemD. Raposo 1,*, André B. Canelas 2 and M. Teresa Barros 1 1, 2 1 Cláudia D. Raposo * , Andr1 é LAQVB. Canelas‐Requimte,and Department M. Teresa of Chemistry, Barros NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829‐516 Caparica, Portugal; [email protected] 12 GlanbiaLAQV-Requimte,‐AgriChemWhey, Department Lisheen of Chemistry, Mine, Killoran, NOVA Moyne, School E41 of ScienceR622 Co. and Tipperary, Technology, Ireland; canelas‐ [email protected] NOVA de Lisboa, 2829-516 Caparica, Portugal; [email protected] 2* Correspondence:Glanbia-AgriChemWhey, [email protected]; Lisheen Mine, Tel.: Killoran, +351‐212948550 Moyne, E41 R622 Tipperary, Ireland; [email protected] * Correspondence: [email protected]; Tel.: +351-212948550 Abstract: Lectins are a class of proteins responsible for several biological roles such as cell‐cell in‐ Abstract:teractions,Lectins signaling are pathways, a class of and proteins several responsible innate immune for several responses biological against roles pathogens. such as Since cell-cell lec‐ interactions,tins are able signalingto bind to pathways, carbohydrates, and several they can innate be a immuneviable target responses for targeted against drug pathogens. delivery Since sys‐ lectinstems. In are fact, able several to bind lectins to carbohydrates, were approved they by canFood be and a viable Drug targetAdministration for targeted for drugthat purpose. delivery systems.Information In fact, about several specific lectins carbohydrate were approved recognition by Food by andlectin Drug receptors Administration was gathered for that herein, purpose. plus Informationthe specific organs about specific where those carbohydrate lectins can recognition be found by within lectin the receptors human was body.
    [Show full text]
  • Differential Gene Expression in the Skin of Xiphophorus
    DIFFERENTIAL GENE EXPRESSION IN THE SKIN OF XIPHOPHORUS MACULATUS JP 163 B IN RESPONSE TO FULL SPECTRUM (10,000 K) FLUORESCENT LIGHT by Kaela Caballero, B.S. A thesis submitted to the Graduate Council of Texas State University in partial fulfillment of the requirements for the degree of Master of Science with a Major in Biochemistry August 2015 Committee Members: Ronald Walter, Chair Rachell Booth Steven Whitten COPYRIGHT by Kaela L. Caballero 2015 FAIR USE AND AUTHOR’S PERMISSION STATEMENT Fair Use This work is protected by the Copyright Laws of the United States (Public Law 94-553, section 107). Consistent with fair use as defined in the Copyright Laws, brief quotations from this material are allowed with proper acknowledgment. Use of this material for financial gain without the author’s express written permission is not allowed. Duplication Permission As the copyright holder of this work I, Kaela L. Caballero, authorize duplication of this work, in whole or in part, for educational or scholarly purposes only. DEDICATION To my parents and family, who have always supported and encouraged me, my education and my coffee addiction. And to Max, my study buddy; where you have gone, there is no need for coffee fueled late nights. Rest in peace. ACKNOWLEDGEMENTS This work could not have been accomplished without the support and mentorship that I have received throughout my life from family, teachers, mentors and friends. It is impossible to name everyone here, but I would like to use a few lines to thank those that have helped me achieve my goals. Thank you to Dr.
    [Show full text]
  • Expression of a Mirna Targeting Mutated SOD1 in Astrocytes Induces Motoneuron Plasticity and Improves Neuromuscular Function in ALS Mice
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.08.425706; this version posted January 9, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Expression of a miRNA targeting mutated SOD1 in astrocytes induces motoneuron plasticity and improves neuromuscular function in ALS mice Rochat C.1, Bernard-Marissal N.1,6, Pradervand S.3, Perrin F.E.4, Raoul C.5, Aebischer P.1, Schneider B.L.1,2* 1 Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland 2 Bertarelli Platform for Gene Therapy, Ecole Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland 3 Genomic Technologies Facility, University of Lausanne, Lausanne, Switzerland. 4 INSERM U1198, University of Montpellier, EPHE, Place Eugène Bataillon CC105, F-34095, Montpellier, France 5 The Neuroscience Institute of Montpellier, Inserm UMR1051, Univ Montpellier, Saint Eloi Hospital, Montpellier, France 6 Aix Marseille Univ, INSERM, MMG, Marseille, France *Correspondence should be addressed to B.L.S. ([email protected]) Short title: miRNA gene therapy targeting astrocytes in ALS Study was performed in Lausanne, Switzerland Current address of corresponding author: Bernard Schneider EPFL SV PTECH PTBTG Ch. des Mines 9 CH-1202 Genève Switzerland Email: [email protected] Tel: +41 21 693 95 05 bioRxiv preprint doi: https://doi.org/10.1101/2021.01.08.425706; this version posted January 9, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Loss of the Mammalian APC/C Activator FZR1 Shortens G1 and Lengthens S Phase but Has Little Effect on Exit from Mitosis
    4208 Research Article Loss of the mammalian APC/C activator FZR1 shortens G1 and lengthens S phase but has little effect on exit from mitosis Reinhard Sigl1, Cornelia Wandke1, Veronika Rauch1, Jane Kirk2, Tim Hunt2 and Stephan Geley1,* 1Division of Molecular Pathophysiology, Biocenter, Innsbruck Medical University, Innsbruck, Austria 2Clare Hall Laboratories, Cancer Research UK, South Mimms, England, UK *Author for correspondence ([email protected]) Accepted 10 September 2009 Journal of Cell Science 122, 4208-4217 Published by The Company of Biologists 2009 doi:10.1242/jcs.054197 Summary The anaphase-promoting complex/cyclosome (APC/C) is knockdown of p53 in U2OS cells with inducible FZR1 siRNA essential for progression through mitosis. At anaphase onset, also failed to restore their proliferative capacity. Thus, the the APC/C requires the activator protein CDC20 to target proliferation defects are a direct consequence of the genetic securin and cyclin B1 for proteasome-dependent degradation, damage inflicted by loss of FZR1 function and are largely but then depends on the CDC20-related protein FZR1 (also independent of p53. In summary, mammalian FZR1 is not known as CDH1) to remain active until the onset of the next S required for the completion of mitosis, but is an important phase. To investigate the role of FZR1 in mammalian cells, we regulator of G1 phase and is required for efficient DNA used RNAi in human cell lines and conditional gene targeting replication in human and mouse somatic cells. in mouse embryonic fibroblasts. In neither case was FZR1 required for exit from mitosis, but in cells lacking FZR1, the Supplementary material available online at G1 phase was shortened and the S phase was prolonged.
    [Show full text]